Robert J Palmisano 13D and 13G filings for AEON Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-22 4:02 pm Purchase | 2024-07-25 | 13D | AEON Biopharma, Inc. AEON | Robert J Palmisano | 2,265,000 5.700% | 2,265,000 (New Position) | Filing |